Edwards Lifesciences (EW) EBT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.35% |
| Dec 31, 2025 | -23.98% |
| Sep 30, 2025 | -0.89% |
| Jun 30, 2025 | 34.36% |
| Mar 31, 2025 | 3.55% |
| Dec 31, 2024 | 4.34% |
| Sep 30, 2024 | 5.95% |
| Jun 30, 2024 | 7.20% |
| Mar 31, 2024 | 5.95% |
| Dec 31, 2023 | 190.25% |
| Sep 30, 2023 | 9.28% |
| Jun 30, 2023 | 1.85% |
| Mar 31, 2023 | 8.63% |
| Dec 31, 2022 | -8.18% |
| Sep 30, 2022 | 13.97% |
| Jun 30, 2022 | 17.71% |
| Mar 31, 2022 | 8.23% |
| Dec 31, 2021 | 13.43% |
| Sep 30, 2021 | 16.11% |
| Jun 30, 2021 | 26.41% |
| Mar 31, 2021 | 16.26% |
| Dec 31, 2020 | 16.35% |
| Sep 30, 2020 | 19.31% |
| Jun 30, 2020 | -26.06% |
| Mar 31, 2020 | 17.54% |
| Dec 31, 2019 | 18.88% |
| Sep 30, 2019 | 20.13% |
| Jun 30, 2019 | -19.71% |
| Mar 31, 2019 | 29.17% |
| Dec 31, 2018 | -15.08% |
| Sep 30, 2018 | 20.04% |
| Jun 30, 2018 | 15.81% |
| Mar 31, 2018 | 6.69% |
| Dec 31, 2017 | 35.27% |
| Sep 30, 2017 | 17.79% |
| Jun 30, 2017 | 17.99% |
| Mar 31, 2017 | 27.95% |
| Dec 31, 2016 | 23.91% |
| Sep 30, 2016 | 26.31% |
| Jun 30, 2016 | 18.35% |
| Mar 31, 2016 | 16.72% |
| Dec 31, 2015 | 27.11% |
| Sep 30, 2015 | 17.88% |
| Jun 30, 2015 | 16.45% |
| Mar 31, 2015 | 19.93% |
| Dec 31, 2014 | 44.50% |
| Sep 30, 2014 | 5.07% |
| Jun 30, 2014 | 66.90% |